In response to a request for recommendations to help address rising drug costs, the National Association of Accountable Care Organizations (NAACOS) has submitted comments to the Senate Committee on Health, Education, Labor, and Pensions.
In response to a request for recommendations to help address rising drug costs, the National Association of Accountable Care Organizations (NAACOS) has submitted comments to the Senate Committee on Health, Education, Labor, and Pensions. They recommend that Congress continue to ensure that the Medicare Shared Savings Program (MSSP remains strong and encourages robust participation, explaining that Medicare ACO programs like MSSP are the largest value-based payment models in the country and an essential tool in moving toward a value-based healthcare system.
NAACOS also recommended that Congress consider amendments to 42. C.F.R. Part 2, which requires patients to submit written consent prior to the disclosure of their substance use treatment records. According to NAACOS, these requirements are often challenging and they limit whole-person integrated care and care coordination. Read all the comments.
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More